Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model

Beredaki, M.I., Georgiou, P.C., M. Siopi (Maria), Kanioura, L., D. Andes, Arendrup, MC, J.W. Mouton (Johan) and J. Meletiadis (Joseph)

2020

Additional Metadata
Persistent URL	doi.org/10.1128/aac.00170-20, hdl.handle.net/1765/128387
Journal	Antimicrobial Agents and Chemotherapy
Rights	no subscription
Organisation	Department of Medical Microbiology and Infectious Diseases
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Beredaki, M.I., Georgiou, P.C., Siopi, M., Kanioura, L., Andes, D., Arendrup, MC, … Meletiadis, J. (2020). Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy, 64(6). doi:10.1128/aac.00170-20

Publication